Benitec Biopharma Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Operating Expenses
Income Breakdown
Revenue
$0
R&D↑+8.3% +$449K
$6M
D&A↑+0.0% +$0
$14K
Operating Income↓-23.8% -$3M
$-13M
EBITDA↓-23.8% -$3M
$-13M
Interest Expense↑+68.9% +$567K
$1M
Net Income↓-23.9% -$2M
$-12M
Operating Margin
—
Net Margin
—
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR Foreign Differential (pp)↓-0.0pts
0.0%
Operating Lease Cost↑+0.0% +$0
$100K
Revenue YoY Variation
-100.0%
Income YoY Variation↑+32.2pts
-23.8%
Revenue QoQ Variation
—
Income QoQ Variation↑+50.1pts
-36.5%